fda glp-1 warning news november 2025 warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain FDA warns Novo Nordisk of

Beyond just lowering your blood sugar, GLP-1 drugs affect the entire gastrointestinal system and even the brain to produce weight loss

More people who took semaglutide (86 percent) lost at least five percent of their body weight compared with those on placebo (13 percent)

But as I got older, nothing seemed to work anymore

Effects of cotadutide on metabolic and hepatic parameters in adults with overweight or obesity and type 2 diabetes: A 54-Week randomized phase 2b study

Discontinuing GLP-1 receptor agonist therapy leads to predictable physiological changes as drug levels decline and the pharmacological effects diminish

GLP-1, or glucagon-like peptide-1, is a peptide hormone made by the small intestine and helps reduce glucose levels by stimulating insulin and reducing glucagon secretion